BMY vs UFPI · P/E 17, rev $24.46B vs P/E 18, rev $3.34B
Bristol-Myers Squibb Company (BMY) versus Ufp Industries Inc (UFPI) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Ufp Industries Inc (UFPI) is a lumber & wood production company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported UFPI revenue for 2026-06-27 was $3.34B. Net income was $133.6M. UFPI currently screens at market cap $4.74B and trailing P/E 18.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. UFPI currently screens at market cap $4.74B and trailing P/E 18.3.
Not investment advice. Open the BMY and UFPI stock pages for the full models.
Not investment advice.